Field Service Engineer II (LCMS) (Chantilly, VA)
Thermo Fisher Scientific- Full Time
- Junior (1 to 2 years)
Candidates should possess a Bachelor's degree in Electrical/Electronics/informatic Engineering, Mechanical Engineering, related degree in biotechnology/biomedical or equivalent work experience and knowledge. Some experience working within a Field Service engineer role is preferred, along with fluency in both English and Dutch language skills. A valid driving license within The Netherlands is required, with flexibility to travel up to 75% across the Benelux region (Netherlands, Luxemburg, and Belgium), and occasional travel Europe-wide.
As a Field Service Engineer 2, the individual will partner with customers to install and maintain Illumina hardware, providing troubleshooting and complaint resolution. They will serve as an engineering consultant during pre- and post-sales activities, collaborating with the commercial team to maximize sales growth, support instrument uptime, and customer satisfaction. The role involves providing onsite technical assistance to customers, Field Applications Scientists/Specialists, and Territory Account Managers, utilizing service manuals and facilitating remote connectivity. Responsibilities also include coordinating service requests, maintaining inventory levels, establishing customer relationships, ensuring effective problem resolution, participating in project teams, executing qualification and validation products, and coordinating new installations while representing the company professionally and ethically.
Supports genomics startups through funding and resources
Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.